Skip to main content

Table 4 Associations of cytoplasmic and membranous ezrin expression with clinicopathological parameters

From: Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker

  

Min cytoplasmic

Mean cytoplasmic

Max cytoplasmic

Min membranous

Mean membranous

Max membranous

Factor

n (%)

Mean, median (range)

P

Mean, median (range)

P

Mean, median (range)

P

Mean, median (range)

P

Mean, median (range)

P

Mean, median (range)

P

Age

             

≤ average

129

0.95, 1.00

0.332

1.03, 1.00

0.77

1.12, 1.00

0.77

0.46, 0.15

0.234

0.59, 0.37

0.423

0.72, 0.67

0.680

(49.0)

(0.00-2.00)

 

(0.00-2.13)

3

(0.00-2.25)

7

(0.00-2.50)

 

(0.00-2.50)

 

(0.00-2.50)

 

> average

134

0.90, 2.00

 

1.00, 1.00

 

1.12, 1.00

 

0.35, 0.10

 

0.52, 0.32

 

0.69, 0.50

 

(51.0)

(0.00-2.00)

 

(0.00-2.28)

 

(0.00-2.90)

 

(0.00-2.13)

 

(0.00-2.25)

 

(0.00-2.38)

 

Gender

             

Female

81

0.91, 1.00

0.781

1.00, 1.00

0.76

1.08, 1.00

0.89

0.46, 0.15

0.348

0.61, 0.62

0.362

0.77, 0.97

0.576

(30.8)

(0.00-2.00)

 

(0.00-2.28)

0

(0.00-2.90)

1

(0.00-1.70)

 

(0.00-1.70)

 

(0.00-2.38)

 

Male

182

0.92, 1.00

 

1.03, 1.00

 

1.13, 1.00

 

0.37, 0.10

 

0.53, 0.32

 

0.68, 0.51

 

(69.2)

(0.00-2.00)

 

(0.00-2.13)

 

(0.00-2.25)

 

(0.00-2.50)

 

(0.00-2.50)

 

(0.00-2.50)

 

T-stage

             

Ta

114

0.95, 1.00

0.005

1.05, 1.00

0.00

1.15, 1.00

0.00

0.50, 0.20

0.001

0.66, 0.59

<0.001

0.83, 0.90

<0.001

(43.3)

(0.00-2.00)

 

(0.00-2.15)

4

(0.00-2.80)

5

(0.00-2.13)

 

(0.00-2.25)

 

(0.00-2.38)

 

T1

84

0.99, 1.00

 

1.09, 1.05

 

1.19, 1.10

 

0.41, 0.15

 

0.62, 0.54

 

0.83, 0.72

 

(31.9)

(0.00-2.00)

 

(0.00-2.28)

 

(0.00-2.90)

 

(0.00-2.38)

 

(0.00-2.38)

 

(0.00-2.38)

 

T2-4

65

0.78, 0.95

 

0.88, 0.97

 

0.97, 1.00

 

0.21, 0.05

 

0.27, 0.07

 

0.34, 0.10

 

(24.7)

(0.00-2.00)

 

(0.00-2.00)

 

(0.00-2.10)

 

(0.00-2.50)

 

(0.00-2.50)

 

(0.00-2.50)

 

Grade

             

Low

133

1.01, 1.00

0.014

1.10, 1.00

0.02

1.19, 1.00

0.11

0.49, 0.15

0.008

0.66, 0.60

<0.001

0.84, 0.97

<0.001

(50.6)

(0.00-2.00)

 

(0.00-2.28)

5

(0.00-2.90)

4

(0.00-2.05)

 

(0.00-2.50)

 

(0.00-2.50)

 

High

130

0.83, 1.00

 

0.94, 1.00

 

1.04, 1.00

 

0.31, 0.10)

 

0.44, 0.20

 

0.57, 0.20

 

(49.4)

(0.00-2.00)

 

(0.00-2.00)

 

(0.00-2.00)

 

(0.00-1.90)

 

(0.00-2.14)

 

(0.00-2.38)

 

Location

             

Bladder

258

0.93, 1.00

0.934

1.03, 1.00

0.52

1.13, 1.00

0.51

0.40, 0.10

0.136

0.56, 0.37

0.040

0.71, 0.52

0.023

(98.1)

(0.00-2.00)

 

(0.00-2.28)

9

(0.00-2.90)

0

(0.00-2.50)

 

(0.00-2.50)

 

(0.00-2.50)

 

Other

5

0.82, 1.00

 

0.83, 1.00

 

0.84, 1.00

 

0.24, 0.00

 

0.24, 0.00

 

0.24, 0.00

 

(1.9)

(0.00-1.10)

 

(0.00-1.10)

 

(0.00-1.10)

 

(0.00-1.20)

 

(0.00-1.20)

 

(0.00-1.20)

 

Smoking status

             

Regularly

93

0.98, 1.00

0.384

1.07, 1.00

0.22

1.17, 1.00

0.15

0.42, 0.10

0.461

0.58, 0.50

0.300

0.75, 0.60

0.360

(35.4)

(0.00-2.00)

 

(0.00-2.13)

3

(0.00-2.25)

6

(0.00-2.50)

 

(0.00-2.50)

 

(0.00-2.50)

 

Occasionally

15

0.89, 1.00

 

1.05, 1.00

 

1.21, 1.00

 

0.43, 0.20

 

0.57, 0.55

 

0,72, 0.90

 

(5.7)

(0.05-1.50)

 

(0.08-1.55)

 

(0.10-2.00)

 

(0.00-1.20)

 

(0.00-1.31)

 

(0.00-1.50)

 

Former

113

0.85, 1.00

 

0.93, 1.00

 

1.01, 1.00

 

0.34, 0.10

 

0.49, 0.22

 

0.63, 0.35

 

(43.0)

(0.00-2.00)

 

(0.00-2.00)

 

(0.00-2.10)

 

(0.00-2.38)

 

(0.00-2.38)

 

(0.00-2.38)

 

Never

42

1.00, 1.00

 

1.12, 1.02

 

1.24, 1.05

 

0.49, 0.17

 

0.65, 0.56

 

0.83, 0.75

 

(16.0)

(0.00-1.85)

 

(0.00-2.28)

 

(0.00-2.90)

 

(0.00-1.75)

 

(0.00-1.75)

 

(0.00-2.00)